Key result
Multimodal genetic testing detects novel cryptic EWSR1 rearrangements in ~38% of pediatric Ewing sarcoma cases.
Why the study?
Recognition of complex and/or cryptic EWSR1 gene rearrangements/fusions and other chromosome abnormalities in pediatric Ewing sarcomas is important for accurate diagnosis, prognosis, and treatment outcomes.
Observational (n=8)
No
The use of combined genetic methods is important for identifying complex and cryptic EWSR1 gene rearrangements and other chromosomal abnormalities in pediatric Ewing sarcoma to aid in accurate diagnosis.
May support multimodal testing to detect cryptic EWSR1 rearrangements in pediatric Ewing sarcoma; hypothesis-generating and requires larger validation before changing practice.
Ewing sarcomas (ES) are rare small round cell sarcomas often affecting children and characterized by gene fusions involving one member of the FET family of genes (usually EWSR1) and a member of the ETS family of transcription factors (usually FLI1 or ERG). The detection of EWSR1 rearrangements has important diagnostic value. Here, we conducted a retrospective review of 218 consecutive pediatric ES at diagnosis and found eight patients having data from chromosome analysis, FISH/microarray, and gene-fusion assay. Three of these eight ES had novel complex/cryptic EWSR1 rearrangements/fusions by chromosome analysis. One case had a t(9;11;22)(q22;q24;q12) three-way translocation involving EWSR1::FLI1 fusion and 1q jumping translocation. Two cases had cryptic EWSR1 rearrangements/fusions, including one case with a cryptic t(4;11;22)(q35;q24;q12) three-way translocation involving EWSR1::FLI1 fusion, and the other had a cryptic EWSR1::ERG rearrangement/fusion on an abnormal chromosome 22. All patients in this study had various aneuploidies with a gain of chromosome 8 (75%), the most common, followed by a gain of chromosomes 20 (50%) and 4 (37.5%), respectively. Recognition of complex and/or cryptic EWSR1 gene rearrangements/fusions and other chromosome abnormalities (such as jumping translocation and aneuploidies) using a combination of various genetic methods is important for accurate diagnosis, prognosis, and treatment outcomes of pediatric ES.
No takes yet. Share an insight, caveat, or question.
Zou et al. (2023) conducted an observational in Pediatric Ewing Sarcoma (n=8). Complex and cryptic EWSR1 gene rearrangements/fusions was evaluated on Frequency of complex/cryptic EWSR1 rearrangements/fusions. Among 8 pediatric patients with Ewing sarcoma, 3 (37.5%) harbored novel complex and cryptic EWSR1 rearrangements or fusions, highlighting the importance of multimodal genetic testing for accurate diagnosis.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: